“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart

Article: BHS guidelines for the diagnosis and the treatment of hairy cell leukaemia

€2.42

SKU: product-article-16214 Category: General

Description
Reviews (0)

Description

BHS guidelines for the diagnosis and the treatment of hairy cell leukaemia

Reviews

There are no reviews yet.

Be the first to review “Article: BHS guidelines for the diagnosis and the treatment of hairy cell leukaemia”

Top

Article: BHS guidelines for the diagnosis and the treatment of hairy cell leukaemia

Description

Reviews

Related products

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Highlights in breast cancer

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in genitourinary cancers